Avinger, which sells an image-guided, catheter-based system to treat peripheral arterial disease, filed on Tuesday with the SEC to raise up to $69 million in an initial public offering.
The Redwood City, CA-based company, which was founded in 2007 and booked $12 million in sales for the 12 months ended September 30, 2014, plans to list on the NASDAQ under the symbol AVGR. Canaccord Genuity and Cowen & Company are the joint bookrunners on the deal. No pricing terms were disclosed.
